This tendency was pronounced in LCHAD deficiency, which exhibited a mortality rate of 0–6.6% in NBS-identified patients compared with 23–93.8% in clinically diagnosed patients. The gene discussed is HADHA; the disease is hyperinsulinemic hypoglycemia, familial, 4.